Article metrics

Download PDFPDF

737 A phase 1/1b study of the tumor-activated IL-2 prodrug WTX-124 alone or in combination with pembrolizumab in patients with immunotherapy-sensitive locally advanced or metastatic solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to September 2024

AbstractFullPdf
Nov 2023376026
Dec 202392016
Jan 20245508
Feb 20245205
Mar 20248407
Apr 20248405
May 202484011
Jun 20247703
Jul 202410007
Aug 20248209
Sep 20246608
Total11520105